| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |